Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review. [PDF]
Sanwick AM, Chaple IF.
europepmc +1 more source
Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET [PDF]
Jin Su Kim
core +1 more source
Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers. [PDF]
Kuznetsov M +6 more
europepmc +1 more source
Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology. [PDF]
Tomiyoshi K +7 more
europepmc +1 more source
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma. [PDF]
Waked A +7 more
europepmc +1 more source
Cutaneous Neuroendocrine Metastases of Visceral Origin Responsive to Surgical Resection and Targeted Radionuclide Therapy. [PDF]
Tung-Hahn E, El-Haddad G, Strosberg J.
europepmc +1 more source
Targeted radionuclide therapy against GARP expressing T regulatory cells after tumour priming with external beam radiotherapy in a murine syngeneic model. [PDF]
Bellaye PS +15 more
europepmc +1 more source
Dosimetry of alpha-emitting radionuclides for targeted radionuclide therapy
Targeted radionuclide therapy (TRT) is a nuclear medicine-based cancer treatment technique that consists in coupling a radionuclide with a carrier molecule able to specifically target cancer cells. In this context, the radionuclides commonly used in clinic are mainly β− emitters (177Lu, 131I, 90Y), although an α-emitter (223Ra) has been recently ...
openaire +1 more source
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence. [PDF]
Dieudonné A +13 more
europepmc +1 more source
Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response. [PDF]
Yang Y +5 more
europepmc +1 more source

